GLDC and neoplasm: These findings are consistent with the observed upregulation of key one-carbon metabolic enzymes (PHGDH, PSAT1, GLDC, SHMT1/2) in PDAC tumors from TCGA-PAAD data (Supplementary Figure 5), suggesting increased tumor utilization of circulating one-carbon metabolites.